|
GB0603683D0
(en)
*
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
AR064333A1
(es)
|
2006-12-14 |
2009-04-01 |
Schering Corp |
Anticuerpo anti-tslp de diseno
|
|
AU2009206306B2
(en)
|
2008-01-25 |
2013-06-06 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
CA2779384C
(en)
|
2009-11-04 |
2018-02-27 |
Schering Corporation |
Engineered anti-tslp antibody
|
|
EP2619226B1
(en)
*
|
2010-09-22 |
2018-09-12 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
EP2773774A4
(en)
*
|
2011-11-03 |
2015-06-10 |
Merck Sharp & Dohme |
BIOMARKERS FOR TSLP TREATMENT
|
|
DK3431492T3
(da)
*
|
2012-04-27 |
2021-03-08 |
Amgen Inc |
Humane cd30-ligandantigen-bindende proteiner
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
CA2923145C
(en)
|
2013-09-05 |
2025-09-16 |
Amgen Inc. |
MOLECULES CONTAINING FCS AND EXHIBITING PREDICTABLE, UNIFORM AND REPRODUCIBLE GLYCOFORM PROFILES
|
|
WO2015118124A1
(en)
*
|
2014-02-06 |
2015-08-13 |
Vib Vzw |
Thymic stromal lymphopoietin receptor antagonist
|
|
JP6640113B2
(ja)
|
2014-05-07 |
2020-02-05 |
アムジエン・インコーポレーテツド |
衝撃低減要素を有する自動注入器
|
|
MX377275B
(es)
|
2014-05-16 |
2025-03-07 |
Amgen Inc |
Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2).
|
|
CN112237662B
(zh)
|
2014-06-03 |
2022-10-21 |
安姆根有限公司 |
药物递送系统和使用方法
|
|
WO2016061220A2
(en)
|
2014-10-14 |
2016-04-21 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
IL287947B2
(en)
|
2014-10-23 |
2024-08-01 |
Amgen Inc |
Viscosity reduction of pharmaceutical preparations
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
WO2016138434A1
(en)
|
2015-02-27 |
2016-09-01 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
EP3268032A1
(en)
*
|
2015-03-11 |
2018-01-17 |
GlaxoSmithKline Intellectual Property Development Limited |
Tslp binding proteins
|
|
MX383614B
(es)
*
|
2015-05-21 |
2025-03-14 |
Harpoon Therapeutics Inc |
Proteinas de union triespecificas y metodos de uso.
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
US10000561B2
(en)
*
|
2015-09-09 |
2018-06-19 |
Novartis Ag |
Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
|
|
KR20180042433A
(ko)
|
2015-09-09 |
2018-04-25 |
노파르티스 아게 |
흉선 기질 림포포이에틴 (tslp)-결합 항체 및 항체의 사용 방법
|
|
ES2755717T3
(es)
|
2015-12-09 |
2020-04-23 |
Amgen Inc |
Autoinyector con tapa de señalización
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
RU2021129189A
(ru)
|
2016-01-22 |
2021-11-15 |
Мерк Шарп И Доум Корп. |
Антитела против фактора свертывания xi
|
|
GB201615588D0
(en)
*
|
2016-09-14 |
2016-10-26 |
Glaxosmithkline Ip Dev Ltd |
TSLP Binding Proteins
|
|
US11200298B2
(en)
|
2016-03-15 |
2021-12-14 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
EP3440103A1
(en)
|
2016-04-05 |
2019-02-13 |
Vib Vzw |
Novel tslp inhibitors
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
EP3455142B1
(en)
|
2016-05-13 |
2023-08-09 |
Amgen Inc. |
Vial sleeve assembly
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
US10100106B2
(en)
|
2016-05-20 |
2018-10-16 |
Harpoon Therapeutics, Inc. |
Single domain serum albumin binding protein
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
MY201852A
(en)
|
2016-06-14 |
2024-03-20 |
Merck Sharp & Dohme Llc |
Anti-coagulation factor xi antibodies
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
RU2721582C1
(ru)
*
|
2016-08-05 |
2020-05-20 |
И-Байолоджикс Инк. |
Антитела против лиганда-1 запрограммированной смерти (PD-L1) и их применение
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
TWI857389B
(zh)
|
2016-12-01 |
2024-10-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
WO2018136398A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
UA126571C2
(uk)
|
2017-01-24 |
2022-11-02 |
Ай-Маб Байофарма Юес Лімітед |
Антитіло до cd73 та його застосування
|
|
US11369736B2
(en)
|
2017-02-17 |
2022-06-28 |
Amgen Inc. |
Cannula insertion and retraction mechanisms
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP7377596B2
(ja)
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
|
EP3592404A1
(en)
|
2017-03-09 |
2020-01-15 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
KR102651078B1
(ko)
|
2017-03-28 |
2024-03-22 |
암겐 인코포레이티드 |
플런저 로드 및 주사기 조립 시스템 및 방법
|
|
JP7330896B2
(ja)
|
2017-04-12 |
2023-08-22 |
アムジェン インコーポレイテッド |
抗ｔｓｌｐ抗体による喘息治療
|
|
ES3036143T3
(en)
|
2017-04-28 |
2025-09-15 |
Amgen Inc |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
|
JP7200134B2
(ja)
|
2017-06-08 |
2023-01-06 |
アムジエン・インコーポレーテツド |
トルク駆動式薬物送達デバイス
|
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
JP7195276B2
(ja)
|
2017-06-22 |
2022-12-23 |
アムジエン・インコーポレーテツド |
デバイス起動による衝突／衝撃の低減
|
|
MA49461A
(fr)
|
2017-06-23 |
2020-04-29 |
Amgen Inc |
Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur
|
|
CN109206514B
(zh)
*
|
2017-07-03 |
2019-10-08 |
拜西欧斯（北京）生物技术有限公司 |
Tslp单克隆抗体及其制备方法和应用
|
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
|
EP3655063A1
(en)
|
2017-07-21 |
2020-05-27 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
MA49677A
(fr)
|
2017-07-25 |
2021-04-21 |
Amgen Inc |
Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
|
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
BR112020001922A2
(pt)
|
2017-08-01 |
2020-08-04 |
Amgen Inc. |
sistemas e métodos para realização de um ensaio de glicanas em tempo real de uma amostra
|
|
JP7237022B2
(ja)
|
2017-08-01 |
2023-03-10 |
アムジエン・インコーポレーテツド |
質量分析法による分析用ポリペプチド試料のリアルタイム調製のためのシステム及び方法
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
CA3071783A1
(en)
|
2017-08-16 |
2019-02-21 |
Michael D. Howell |
Compositions and methods for treatment of atopic dermatitis and treatment selection
|
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
SI3694529T1
(sl)
|
2017-10-13 |
2024-10-30 |
Harpoon Therapeutics, Inc. |
Trispecifične beljakovine in načini uporabe
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
WO2019090086A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
|
US20200261648A1
(en)
|
2017-11-06 |
2020-08-20 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
IL273664B1
(en)
|
2017-11-06 |
2026-02-01 |
Amgen Inc |
Full-fledged assemblies and related methods
|
|
IL319987A
(en)
|
2017-11-10 |
2025-06-01 |
Amgen Inc |
Plungers for drug delivery devices
|
|
SG11202003004RA
(en)
|
2017-11-16 |
2020-04-29 |
Amgen Inc |
Door latch mechanism for drug delivery device
|
|
MX2020009458A
(es)
|
2018-03-13 |
2020-10-12 |
Amgen Inc |
Digestion secuencial de polipeptidos para analisis espectrometrico de masas.
|
|
ES2965064T3
(es)
|
2018-03-13 |
2024-04-10 |
Amgen Inc |
Métodos para la preparación de polipéptidos resistentes a tripsina para análisis espectrométrico de masas
|
|
CN119639849A
(zh)
|
2018-03-26 |
2025-03-18 |
美国安进公司 |
细胞培养物中产生的抗体的总去岩藻糖基化糖型
|
|
BR112020023330A2
(pt)
|
2018-05-14 |
2021-04-20 |
Harpoon Therapeutics, Inc. |
porção de ligação para ativação condicional de moléculas de imunoglobulina
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
WO2020023451A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CA3103681A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
EP3829692A1
(en)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
EP3856284A1
(en)
|
2018-09-24 |
2021-08-04 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
EP3856771A4
(en)
|
2018-09-25 |
2022-06-29 |
Harpoon Therapeutics, Inc. |
Dll3 binding proteins and methods of use
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
MX2021003492A
(es)
|
2018-10-02 |
2021-06-18 |
Amgen Inc |
Sistemas de inyeccion para la administracion de farmacos con transmision de fuerza interna.
|
|
JP7547325B2
(ja)
|
2018-10-05 |
2024-09-09 |
アムジエン・インコーポレーテツド |
投薬量インジケータを有する薬物送達デバイス
|
|
SG11202103800RA
(en)
|
2018-10-15 |
2021-05-28 |
Amgen Inc |
Drug delivery device having damping mechanism
|
|
AU2019359801B2
(en)
|
2018-10-15 |
2025-01-02 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
ES3010833T3
(en)
|
2018-11-01 |
2025-04-04 |
Amgen Inc |
Drug delivery devices with partial drug delivery member retraction
|
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
US12000775B2
(en)
|
2018-12-14 |
2024-06-04 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
WO2020142693A1
(en)
*
|
2019-01-04 |
2020-07-09 |
Empirico Inc. |
Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcripts
|
|
WO2020168156A1
(en)
|
2019-02-14 |
2020-08-20 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
|
JP7530376B2
(ja)
|
2019-02-20 |
2024-08-07 |
アムジエン・インコーポレーテツド |
タンパク質の安定性を決定する方法
|
|
US20230035363A1
(en)
|
2019-03-04 |
2023-02-02 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
|
JP7691931B2
(ja)
|
2019-03-27 |
2025-06-12 |
アムジェン インコーポレイテッド |
製剤化された生物製剤製品のための、天然存在比での二次元（２ｄ）核磁気共鳴技術によって治療用タンパク質をフィンガープリントする方法
|
|
AU2020263289B2
(en)
|
2019-04-24 |
2025-05-22 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
MX2021014804A
(es)
|
2019-06-04 |
2022-01-18 |
Jiangsu Hengrui Medicine Co |
Anticuerpo capaz de unirse a la linfopoyetina estromal timica y el uso del mismo.
|
|
EP3980786B1
(en)
|
2019-06-05 |
2024-10-16 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
|
CN114401741A
(zh)
|
2019-07-11 |
2022-04-26 |
拓维创新生物科技(香港)有限公司 |
干扰胸腺基质淋巴细胞生成素(tslp)受体信号传导的药剂
|
|
MX2022002149A
(es)
|
2019-08-23 |
2022-03-17 |
Amgen Inc |
Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados.
|
|
AU2020355251A1
(en)
|
2019-09-26 |
2022-04-21 |
Amgen Inc. |
Methods of producing antibody compositions
|
|
RS66646B1
(sr)
*
|
2019-10-28 |
2025-04-30 |
Medimmune Ltd |
Formulacije suvog praška vezujućih antitela za timusni stromalni limfopoetin (tslp) i postupci njihove upotrebe
|
|
CN114887053B
(zh)
*
|
2019-11-29 |
2026-04-24 |
康诺亚生物医药科技（成都）有限公司 |
一种tslp相关病症治疗剂的开发和应用
|
|
CA3155759A1
(en)
*
|
2019-12-13 |
2021-06-17 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Anti-tslp antibody and uses thereof
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
CN111171150B
(zh)
*
|
2020-02-05 |
2020-12-08 |
北京智仁美博生物科技有限公司 |
抗人tslp抗体及其用途
|
|
EP4103605A1
(en)
|
2020-02-13 |
2022-12-21 |
Amgen Inc. |
Treatment of atopic dermatitis with anti-tslp antibody
|
|
PE20230112A1
(es)
|
2020-02-13 |
2023-01-27 |
Amgen Inc |
Formulaciones de anticuerpos anti-tslp humanos y metodos de tratamiento de una enfermedad inflamatoria
|
|
PH12022552132A1
(en)
|
2020-02-18 |
2024-01-29 |
Amgen Inc |
Formulations of human anti-tslp antibodies and methods of using the same
|
|
CN111662379B
(zh)
*
|
2020-05-09 |
2021-03-02 |
江苏省疾病预防控制中心(江苏省公共卫生研究院) |
抗新型冠状病毒的抗体、制备方法和应用
|
|
CN116829177A
(zh)
*
|
2020-05-20 |
2023-09-29 |
纽约市哥伦比亚大学理事会 |
抗SARS-CoV-2的有效中和抗体及其生成和用途
|
|
EP4153625A4
(en)
*
|
2020-05-20 |
2024-09-25 |
The Trustees Of Columbia University In The City Of New York |
STRONG NEUTRALISING ANTIBODIES AGAINST SARS-COV-2, THEIR PRODUCTION AND USE
|
|
WO2021247892A1
(en)
|
2020-06-04 |
2021-12-09 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
EP4214226A1
(en)
|
2020-09-18 |
2023-07-26 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
|
AU2021360897A1
(en)
|
2020-10-15 |
2023-05-25 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
|
MX2023005320A
(es)
|
2020-11-05 |
2023-05-19 |
Amgen Inc |
Materiales y metodos para el procesamiento de proteinas.
|
|
CN114437212B
(zh)
*
|
2020-11-06 |
2023-03-14 |
上海麦济生物技术有限公司 |
抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用
|
|
WO2022117079A1
(zh)
*
|
2020-12-03 |
2022-06-09 |
江苏恒瑞医药股份有限公司 |
结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
CN113501878B
(zh)
|
2021-02-03 |
2022-12-02 |
北京智仁美博生物科技有限公司 |
针对人tslp的多种抗体及其用途
|
|
JP7641393B2
(ja)
*
|
2021-02-04 |
2025-03-06 |
スタイドソン・（ベイジン）・バイオファーマシューティカルズ・カンパニー・リミテッド |
胸腺間質性リンパ球新生因子を特異的に認識する抗体およびその使用
|
|
BR112023022041A2
(pt)
*
|
2021-04-23 |
2023-12-26 |
Amgen Inc |
Anticorpos anti-tslp modificados
|
|
AU2022262421A1
(en)
|
2021-04-23 |
2023-10-19 |
Amgen Inc. |
Anti-tslp antibody compositions and uses thereof
|
|
MX2023013640A
(es)
|
2021-05-21 |
2023-11-30 |
Amgen Inc |
Metodo de optimizacion de una receta de llenado para un contenedor de medicamento.
|
|
CA3217029A1
(en)
*
|
2021-05-30 |
2022-12-08 |
Biolojic Design Ltd. |
Engineered dual binding antibodies and uses thereof
|
|
CN113069543B
(zh)
*
|
2021-06-07 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物
|
|
AR126089A1
(es)
|
2021-06-07 |
2023-09-13 |
Amgen Inc |
Uso de fucosidasa para controlar el nivel de afucosilación de proteínas glucosiladas
|
|
CN113683694B
(zh)
|
2021-09-03 |
2022-05-13 |
江苏荃信生物医药股份有限公司 |
一种抗人tslp单克隆抗体及其应用
|
|
WO2023059607A1
(en)
|
2021-10-05 |
2023-04-13 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
WO2023070948A1
(zh)
*
|
2021-11-01 |
2023-05-04 |
江苏荃信生物医药股份有限公司 |
包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂
|
|
TW202325853A
(zh)
|
2021-11-09 |
2023-07-01 |
美商安進公司 |
治療性蛋白之生產
|
|
CN117209604B
(zh)
*
|
2021-12-02 |
2024-03-22 |
北京东方百泰生物科技股份有限公司 |
一种抗tslp的单克隆抗体、其抗原结合片段及其应用
|
|
CN114369654B
(zh)
*
|
2021-12-21 |
2023-11-07 |
广州市妇女儿童医疗中心 |
川崎病的生物标志物及其应用
|
|
CA3244178A1
(en)
*
|
2021-12-24 |
2023-06-29 |
Inmagene Pte. Ltd. |
NEW ANTI-TSLP ANTIBODY
|
|
AU2023227442A1
(en)
*
|
2022-03-03 |
2024-09-12 |
Pfizer Inc. |
Multispecific antibodies and uses thereof
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US12110324B2
(en)
|
2022-07-22 |
2024-10-08 |
Flagship Pioneering Innovations Vi, Llc |
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
|
|
CN118580343B
(zh)
*
|
2022-10-21 |
2025-08-19 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
UY40500A
(es)
|
2022-10-26 |
2024-04-30 |
Amgen Inc |
Composiciones de anticuerpos anti-tslp y usos de las mismas
|
|
TW202448501A
(zh)
|
2023-02-02 |
2024-12-16 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療慢性鼻竇炎
|
|
EP4678659A1
(en)
*
|
2023-02-23 |
2026-01-14 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Monoclonal antibody preparation targeting tslp
|
|
AU2024256160A1
(en)
|
2023-04-20 |
2025-10-02 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
KR20260013478A
(ko)
|
2023-05-18 |
2026-01-28 |
메디뮨 엘엘씨 |
항-tslp 항체를 사용한 코르티코스테로이드 의존성 천식의 치료
|
|
WO2024259275A1
(en)
|
2023-06-14 |
2024-12-19 |
Bristol-Myers Squibb Company |
Near real time sialic acid quantitation of glycoproteins
|
|
CN121443639A
(zh)
*
|
2023-06-22 |
2026-01-30 |
派拉冈医疗公司 |
结合tslp和tslpr的抗体及其使用方法
|
|
EP4731663A2
(en)
*
|
2023-06-22 |
2026-04-29 |
Paragon Therapeutics, Inc. |
Antibodies that bind interleukin 13 and tslp or tslpr and methods of use
|
|
AU2024325342A1
(en)
|
2023-08-14 |
2026-02-26 |
Amgen Inc. |
Methods for reducing yellow color
|
|
KR20260058856A
(ko)
|
2023-08-25 |
2026-04-29 |
프로테올로직스 유에스 인크. |
항-il-13 다중특이적 항체 작제물 및 이의 용도
|
|
AR134102A1
(es)
*
|
2023-10-12 |
2025-12-03 |
Innovent Biologics Suzhou Co Ltd |
ANTICUERPOS ANTI-IL-4Ra Y USOS DE LOS MISMOS
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025147632A1
(en)
|
2024-01-05 |
2025-07-10 |
Medimmune, Llc |
Treatment of chronic obstructive pulmonary disease with anti-tslp antibody
|
|
WO2025221247A1
(en)
|
2024-04-17 |
2025-10-23 |
Amgen Inc. |
Treatment of eosinophilic esophagitis with anti-tslp antibody
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|
|
WO2025264860A2
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Methods of treating post-covid airway disease
|
|
WO2025265071A1
(en)
*
|
2024-06-21 |
2025-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and methods of use
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
WO2026067826A1
(zh)
*
|
2024-09-30 |
2026-04-02 |
深圳市小分子新药创新中心有限公司 |
抗tslp单域抗体及其衍生物
|
|
WO2026086808A1
(zh)
*
|
2024-10-22 |
2026-04-30 |
海南先声药业有限公司 |
抗tslp抗体及其应用
|
|
WO2026090253A1
(en)
|
2024-10-23 |
2026-04-30 |
Amgen Inc. |
Methods of determining glycan pairing content
|